CLINICAL_TRIALS
trial_result
· 2021-05-24
Clinical Trial Update: A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD [Phase 2]
Summary
Phase 2 pilot trial evaluating alpha-1-antitrypsin for pre-emption of steroid-refractory acute GVHD has been completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: John Levine | Conditions: Graft-versus-host-disease, GVHD | Phase 2 | Status: COMPLETED | Results posted: 2021-05-24